| Literature DB >> 18195137 |
Elliot M Frohman1, Fiona Costello, Olaf Stüve, Peter Calabresi, David H Miller, Simon J Hickman, Robert Sergott, Amy Conger, Amber Salter, Kimberly H Krumwiede, Teresa C Frohman, Laura Balcer, Robert Zivadinov.
Abstract
A major objective in multiple sclerosis therapeutics is to develop strategic targeting of specific injury pathways to provide neuroprotection and potentially even restoration. Here we underscore the potential utility of the anterior visual system for the purpose of modeling neuroprotection in response to novel therapies.Entities:
Mesh:
Year: 2008 PMID: 18195137 DOI: 10.1001/archneurol.2007.10
Source DB: PubMed Journal: Arch Neurol ISSN: 0003-9942